Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of ATAD2 mRNA | CTD | PMID:23649840 | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of ATAD2 mRNA | CTD | PMID:26682919 | 17beta-estradiol | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of ATAD2 mRNA | CTD | PMID:16474171 more ... | 17beta-estradiol | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA | CTD | PMID:17404688 and PMID:20660070 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of ATAD2 mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA | CTD | PMID:20106945 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATAD2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATAD2 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA | CTD | PMID:21570461 and PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA | CTD | PMID:22574217 | 2-methylcholine | affects expression | ISO | ATAD2 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ATAD2 mRNA | CTD | PMID:21179406 | 2-palmitoylglycerol | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ATAD2 mRNA | CTD | PMID:37199045 | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of ATAD2 mRNA | CTD | PMID:20713471 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of ATAD2 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | affects expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Propylthiouracil affects the expression of ATAD2 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ATAD2 mRNA | CTD | PMID:25825206 | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:32553695 | acetamide | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of ATAD2 mRNA | CTD | PMID:31881176 | adefovir pivoxil | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | adefovir dipivoxil results in increased expression of ATAD2 mRNA | CTD | PMID:25596134 | all-trans-retinoic acid | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ATAD2 mRNA | CTD | PMID:16249480 and PMID:33167477 | arsane | affects methylation | ISO | ATAD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ATAD2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | ATAD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ATAD2 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ATAD2 mRNA] | CTD | PMID:32406909 | arsenous acid | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA | CTD | PMID:29266867 | arsenous acid | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ATAD2 mRNA | CTD | PMID:29266867 | azathioprine | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of ATAD2 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ATAD2 mRNA | CTD | PMID:20713471 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene results in increased activity of AHR protein] which results in decreased expression of ATAD2 mRNA | CTD | PMID:32553695 | benzo[a]pyrene | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ATAD2 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ATAD2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | benzo[a]pyrene diol epoxide I | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | bisphenol A | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ATAD2 mRNA | CTD | PMID:16474171 | bisphenol A | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils more ... | CTD | PMID:31601247 and PMID:33376534 | bisphenol A | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ATAD2 mRNA | CTD | PMID:32145629 | bisphenol A | affects expression | ISO | ATAD2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of ATAD2 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ATAD2 mRNA | CTD | PMID:29275510 | bisphenol A | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ATAD2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ATAD2 mRNA | CTD | PMID:26063408 | cadmium dichloride | affects expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Cadmium Chloride affects the expression of ATAD2 mRNA | CTD | PMID:25596134 | caffeine | affects phosphorylation | ISO | ATAD2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of ATAD2 protein | CTD | PMID:35688186 | cefaloridine | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Cephaloridine results in increased expression of ATAD2 mRNA | CTD | PMID:18500788 | CGP 52608 | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATAD2 gene] | CTD | PMID:28238834 | chloroacetaldehyde | affects expression | ISO | ATAD2 (Homo sapiens) | 6480464 | chloroacetaldehyde affects the expression of ATAD2 mRNA | CTD | PMID:25596134 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ATAD2 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of ATAD2 mRNA | CTD | PMID:28472532 | cidofovir anhydrous | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Cidofovir results in increased expression of ATAD2 mRNA | CTD | PMID:25596134 | cisplatin | decreases phosphorylation | EXP | | 6480464 | Cisplatin results in decreased phosphorylation of ATAD2 protein | CTD | PMID:22006019 | cisplatin | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ATAD2 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ATAD2 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ATAD2 mRNA | CTD | PMID:25596134 and PMID:27594783 | cisplatin | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Cisplatin results in decreased expression of ATAD2 mRNA | CTD | PMID:22023808 | clodronic acid | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Clodronic Acid results in increased expression of ATAD2 mRNA | CTD | PMID:25596134 | cobalt dichloride | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of ATAD2 mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ATAD2 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | ATAD2 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of ATAD2 protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of ATAD2 mRNA | CTD | PMID:19167446 | Cuprizon | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of ATAD2 mRNA | CTD | PMID:27523638 | cyclosporin A | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ATAD2 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA | CTD | PMID:26424790 | diarsenic trioxide | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ATAD2 mRNA | CTD | PMID:29266867 | diarsenic trioxide | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA | CTD | PMID:29266867 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ATAD2 mRNA | CTD | PMID:17361019 and PMID:21266533 | dicrotophos | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ATAD2 mRNA | CTD | PMID:28302478 | dioxygen | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of ATAD2 mRNA | CTD | PMID:25596134 | dorsomorphin | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ATAD2 mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA | CTD | PMID:19167446 | Enterolactone | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | 2 and 3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA | CTD | PMID:19167446 | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of ATAD2 mRNA | CTD | PMID:29018328 | FR900359 | affects phosphorylation | ISO | ATAD2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of ATAD2 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene | CTD | PMID:31601247 | genistein | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Genistein results in increased expression of ATAD2 mRNA | CTD | PMID:16474171 | gentamycin | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ATAD2 mRNA | CTD | PMID:22061828 | glycerol 2-phosphate | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA | CTD | PMID:26424790 | indole-3-methanol | affects expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of ATAD2 mRNA | CTD | PMID:21396975 | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ATAD2 mRNA | CTD | PMID:20003209 | ivermectin | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ATAD2 protein | CTD | PMID:32959892 | ketoconazole | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Ketoconazole results in increased expression of ATAD2 mRNA | CTD | PMID:36621641 | L-ascorbic acid | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA | CTD | PMID:26424790 | lidocaine | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of ATAD2 mRNA | CTD | PMID:35283115 | lucanthone | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Lucanthone results in decreased expression of ATAD2 mRNA | CTD | PMID:21148553 | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA | CTD | PMID:36117858 | methyl methanesulfonate | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ATAD2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ATAD2 mRNA | CTD | PMID:28001369 | N,N-diethyl-m-toluamide | multiple interactions | ISO | Atad2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene | CTD | PMID:33148267 | N-methyl-4-phenylpyridinium | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA | CTD | PMID:24810058 | nickel atom | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Nickel results in increased expression of ATAD2 mRNA | CTD | PMID:25583101 | oxaliplatin | decreases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of ATAD2 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | ISO | Atad2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATAD2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATAD2 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ATAD2 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ATAD2 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA | CTD | PMID:36117858 | perfluorononanoic acid | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA | CTD | PMID:32588087 | perfluorooctanoic acid | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of ATAD2 protein | CTD | PMID:26879310 | permethrin | multiple interactions | ISO | Atad2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene | CTD | PMID:33148267 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of ATAD2 mRNA | CTD | PMID:19482888 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of ATAD2 mRNA | CTD | PMID:23091169 | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATAD2 mRNA] | CTD | PMID:19482888 | phytoestrogen | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Phytoestrogens results in increased expression of ATAD2 mRNA | CTD | PMID:18310284 | pirinixic acid | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATAD2 mRNA | CTD | PMID:19710929 | piroxicam | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of ATAD2 mRNA | CTD | PMID:21858171 | progesterone | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA | CTD | PMID:17404688 and PMID:20660070 | progesterone | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Progesterone results in increased expression of ATAD2 mRNA | CTD | PMID:17404688 | resveratrol | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | resveratrol results in increased expression of ATAD2 mRNA | CTD | PMID:19167446 | resveratrol | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD2 mRNA | CTD | PMID:19167446 and PMID:23557933 | SB 431542 | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA | CTD | PMID:27188386 | senecionine | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | senecionine results in increased expression of ATAD2 mRNA | CTD | PMID:32419051 | Senkirkine | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | senkirkine results in increased expression of ATAD2 mRNA | CTD | PMID:32419051 | silicon dioxide | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of ATAD2 mRNA | CTD | PMID:23806026 | sodium arsenite | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ATAD2 mRNA | CTD | PMID:29301061 | sodium arsenite | increases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ATAD2 mRNA | CTD | PMID:34032870 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA | CTD | PMID:21641980 | sunitinib | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ATAD2 mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ATAD2 mRNA | CTD | PMID:27339419 and PMID:31919559 | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of ATAD2 protein | CTD | PMID:24648495 | thapsigargin | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of ATAD2 mRNA | CTD | PMID:22378314 | thioacetamide | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ATAD2 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | ISO | Atad2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA | CTD | PMID:25729387 | trichloroethene | decreases methylation | ISO | Atad2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased methylation of ATAD2 gene | CTD | PMID:27618143 | trichostatin A | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ATAD2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | ATAD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of ATAD2 mRNA | CTD | PMID:30510588 | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of ATAD2 mRNA | CTD | PMID:19042947 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ATAD2 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ATAD2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ATAD2 mRNA | CTD | PMID:17292431 | valproic acid | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ATAD2 mRNA | CTD | PMID:27188386 | vinclozolin | increases expression | ISO | Atad2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of ATAD2 mRNA | CTD | PMID:23034163 | vincristine | decreases expression | ISO | ATAD2 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of ATAD2 mRNA | CTD | PMID:23649840 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
